Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Purcell

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|March 24, 2015
DOCK8 primary immunodeficiency syndromeClaire Purcell, Andrew Cant, Alan D Irvine
Archives of Disease in Childhood. Education and Practice Edition|February 7, 2020
Implementation of a health surveillance clinic for children with Down syndromeNiamh C Lagan, Fiona Mc Grane, Dean Huggard, et al.
Vaccines|September 28, 2023
Correction: Quinn et al. GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic <i>Escherichia coli</i> Infection. <i>Vaccines</i> 2023, <i>11</i>, 175Conor Quinn, Julen Tomás-Cortázar, Oritsejolomi Ofioritse, et al.
Vaccines|January 21, 2023
GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic <i>Escherichia coli</i> InfectionConor Quinn, Julen Tomás-Cortázar, Oritsejolomi Ofioritse, et al.
Archives of Disease in Childhood|February 22, 2022
Communicating a neonatal diagnosis of Down syndrome to parentsKatie Valentine, Sophie Reynolds, Dervla Donegan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|March 24, 2015
DOCK8 primary immunodeficiency syndromeClaire Purcell, Andrew Cant, Alan D Irvine
Archives of Disease in Childhood. Education and Practice Edition|February 7, 2020
Implementation of a health surveillance clinic for children with Down syndromeNiamh C Lagan, Fiona Mc Grane, Dean Huggard, et al.
Vaccines|September 28, 2023
Correction: Quinn et al. GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic <i>Escherichia coli</i> Infection. <i>Vaccines</i> 2023, <i>11</i>, 175Conor Quinn, Julen Tomás-Cortázar, Oritsejolomi Ofioritse, et al.
Vaccines|January 21, 2023
GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic <i>Escherichia coli</i> InfectionConor Quinn, Julen Tomás-Cortázar, Oritsejolomi Ofioritse, et al.
Archives of Disease in Childhood|February 22, 2022
Communicating a neonatal diagnosis of Down syndrome to parentsKatie Valentine, Sophie Reynolds, Dervla Donegan, et al.
Pageof 1